American Association for Cancer Research

Skip to Main Content

Table 5

Follow-up of circulating CEA

Patient no.	Before surgery^a (ng/ml)	Postsurgery^a (ng/ml)	Follow-up^a (ng/ml)
1	32.8	<5	<5 (31 months)
2	91	<5	<5 (34 months)
3	10.8	<5	<5 (30 months)
4	10.3	<5	6.8 (48 months)
5	<5	<5	<5 (43 months)
6	6.9	<5	<5 (38 months)
7	82	No surgery
8	56	22.1	19.8 (6 months)
9	131	41	17.7 (22 months)
10	26.4	<5	5.7 (58 months)
11	247	ND	565 (24 months)
12	20.7	ND	ND
13	17.7	ND	18.7 (4 months)

Patient no.	Before surgery^a (ng/ml)	Postsurgery^a (ng/ml)	Follow-up^a (ng/ml)
1	32.8	<5	<5 (31 months)
2	91	<5	<5 (34 months)
3	10.8	<5	<5 (30 months)
4	10.3	<5	6.8 (48 months)
5	<5	<5	<5 (43 months)
6	6.9	<5	<5 (38 months)
7	82	No surgery
8	56	22.1	19.8 (6 months)
9	131	41	17.7 (22 months)
10	26.4	<5	5.7 (58 months)
11	247	ND	565 (24 months)
12	20.7	ND	ND
13	17.7	ND	18.7 (4 months)

^a

Normal; <5 ng/ml.

^b

ND, not done.